检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:程金涛[1] 梁佳美[1] 张庆芬[1] 周芳[2]
机构地区:[1]山东省临沂市沂水中心医院眼科,山东临沂276400 [2]山东大学齐鲁医院眼科,山东济南251000
出 处:《中国现代医生》2015年第4期58-60,共3页China Modern Doctor
摘 要:目的探讨血清内皮素(ET)、一氧化氮(NO)在视网膜中央静脉阻塞(CRVO)发病中的作用。方法采用放免分析法检测30例CRVO患者和30例健康人及28例无并发症的高血压患者血清ET-1、NO浓度,由专人测定并进行统计学分析。结果 CRVO组血清中ET-1的浓度与正常对照组和高血压对照组相比明显增高(P<0.01),缺血组与非缺血组比较ET-1浓度显著增高(F值=4.029,P<0.01);CRVO组血清中NO浓度与正常对照组和高血压对照组相比明显降低,缺血组与非缺血组比较NO浓度显著降低(F值=5.012,P<0.01)。结论 CRVO患者血清中存在ET浓度的增高和NO浓度的降低,ET和NO参与了CRVO的发病过程,两者在CRVO的发生与发展过程中起重要作用。ET和NO可能反映CRVO患者视网膜缺血的程度。Objective To clarify the possible involvement of endothelin-1(ET-1) and nitric oxide(NO) in the pathogenesis of central retinal vein occlusion(CRVO). Methods ET-1 and NO plasma concentrations were determined by radio immunoassays in a double blind fashion in a group of 30 patients selected with CRVO, in 30 healthy cases and in28 patients with uncomplicated essential hypertension in the same age range, the data were analyzed statisticly. Results The concentration of ET-1 plasma levels of CRVO patients increased significantly compared with both normal subjects and hypertensive patients(P〈0.01). The higher concentration of circulating ET-1 were found in patients with CRVO of the ischaemic type(F=4.029, P〈0.01). The NO plasma levels of CRVO patients decreased significantly compared with both normal subjects and hypertensive patients. The lower concentration of circulating NO were found in patients with CRVO of the ischaemic type(F=5.012,P〈0.01). Conclusion These findings raise the possibility that the increase of circulating ET-1 levels and the decrease of circulating NO levels in patients with CRVO, ET and NO may be markers of the occlusive event, there by suggesting that ET-1 and NO homeostasis may be relevant to CRVO pathogenesis and retinal ischaemic manifestations.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.113